Provenance du réseau au premier degré de Annica Mårtensson
Entité | Type d'entité | Industrie | |
---|---|---|---|
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.
26
| Subsidiary | Pharmaceuticals: Major | 26 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Annica Mårtensson via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Athena Neurosciences LLC
Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Chairman | |
INTERPACE BIOSCIENCES, INC. | Medical Specialties | Chief Executive Officer Director/Board Member | |
INTERMUNE INC | Biotechnology | Corporate Officer/Principal Director/Board Member | |
STANDARD BIOTOOLS INC. | Medical Specialties | Chairman | |
XENCOR, INC. | Biotechnology | General Counsel | |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member | |
KINDRED BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
MALLINCKRODT PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal | |
Sanford C. Bernstein & Co. LLC
Sanford C. Bernstein & Co. LLC Investment Banks/BrokersFinance Sanford C. Bernstein & Co. LLC is a registered broker-dealer headquartered in New York City. The firm was founded in 1967 and is a subsidiary of Alliance Capital Management LLC, ultimately held by Equitable Holdings, Inc. (NYSE: EQH). Sanford C. Bernstein & Co. provides trading and executions services to their clients. | Investment Banks/Brokers | Analyst-Equity | |
San Diego State University | College/University | Graduate Degree | |
Massachusetts Institute of Technology | College/University | Masters Business Admin | |
The University of Texas at Austin | College/University | Graduate Degree | |
Franklin & Marshall College | College/University | Undergraduate Degree | |
The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal | |
Cranfield University | College/University | Doctorate Degree | |
CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Human Resources Officer | |
Universidad Complutense de Madrid | College/University | Doctorate Degree | |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investment Managers | Consultant / Advisor | |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor | |
PROTHENA CORPORATION PLC | Biotechnology | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
OTONOMY | Biotechnology | Director/Board Member Compliance Officer | |
CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Director/Board Member General Counsel | |
University of Maryland Baltimore County | College/University | Doctorate Degree | |
University of Luton | College/University | Undergraduate Degree | |
VENTYX BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Pharmaceuticals: Major | Director/Board Member | |
Circular Genomics, Inc.
Circular Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Circular Genomics, Inc. is a company that specializes in the development of circular RNA-based precision medicine tools, data, and diagnostics for neurology and psychiatry. The company is based in Albuquerque, NM. The company is focused on disrupting and improving the standard of care for major depressive disorder and other neurological diseases. The company offers assays that can assess and direct the best treatment protocol for an individual patient and validate treatment effectiveness in days-to-weeks rather than months. The company was founded in 2021 by Alexander Hafez, Kosmas Karadimitriou, and Nikolaos Mellios. Paul Sargeant has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
IMMUNE DESIGN CORP | Pharmaceuticals: Major | Chief Executive Officer | |
Highlight Therapeutics SL
Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Pharmaceuticals: Major | Chairman | |
VAXCYTE, INC. | Biotechnology | Chairman |
Statistiques
Internationale
Etats-Unis | 37 |
Irlande | 5 |
Royaume-Uni | 5 |
Espagne | 4 |
Canada | 3 |
Sectorielle
Health Technology | 31 |
Consumer Services | 10 |
Finance | 6 |
Commercial Services | 4 |
Health Services | 2 |
Opérationnelle
Corporate Officer/Principal | 64 |
Director/Board Member | 60 |
Independent Dir/Board Member | 24 |
Undergraduate Degree | 20 |
Chief Executive Officer | 19 |
Relations les plus connectées
Insiders | |
---|---|
Lars Ekman | 21 |
Nancy Lurker | 20 |
Richard H. Chin | 17 |
Theodore Schroeder | 16 |
Carlos Paya | 14 |
James Knight | 11 |
Jessica Oien | 10 |
David Feigal | 10 |
Allison Hulme | 9 |
Martin Koller | 9 |
Mark W. Lotz | 9 |
Fortunato Rocca | 9 |
Tara Nickerson | 8 |
Douglas Love | 8 |
Rampurna Prasad Gullapalli | 7 |
- Bourse
- Insiders
- Annica Mårtensson
- Connexions Sociétés